The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?
|
|---|---|
| Published in |
Frontiers in immunology, May 2020
|
| DOI | 10.3389/fimmu.2020.01248 |
| Pubmed ID | |
| Authors |
Athar Khalil, Amina Kamar, Georges Nemer |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 7 | 16% |
| United States | 6 | 14% |
| Canada | 2 | 5% |
| Lebanon | 2 | 5% |
| Switzerland | 2 | 5% |
| Germany | 1 | 2% |
| Ireland | 1 | 2% |
| Australia | 1 | 2% |
| Bosnia and Herzegovina | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 19 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 37 | 86% |
| Scientists | 5 | 12% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 150 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 14% |
| Student > Ph. D. Student | 13 | 9% |
| Other | 13 | 9% |
| Student > Master | 12 | 8% |
| Student > Doctoral Student | 10 | 7% |
| Other | 37 | 25% |
| Unknown | 44 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 25% |
| Nursing and Health Professions | 13 | 9% |
| Biochemistry, Genetics and Molecular Biology | 11 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Chemistry | 4 | 3% |
| Other | 24 | 16% |
| Unknown | 52 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2024.
All research outputs
#625,337
of 26,485,222 outputs
Outputs from Frontiers in immunology
#581
of 33,463 outputs
Outputs of similar age
#18,733
of 434,551 outputs
Outputs of similar age from Frontiers in immunology
#23
of 710 outputs
Altmetric has tracked 26,485,222 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,463 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 710 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.